Multiple differences in gene expression in regulatory Vα24JαQ T cells from identical twins discordant for type I diabetes

  1. S. Brian Wilson*,,
  2. Sally C. Kent,
  3. Heidi F. Horton§,
  4. Andrew A. Hill§,
  5. Paul L. Bollyky,
  6. David A. Hafler,
  7. Jack L. Strominger, and
  8. Michael C. Byrne§,
  1. *Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, MA 02115; Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115; §Genetics Institute, Cambridge, MA 02140; Harvard Medical School, Boston, MA 02115; and Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138
  1. Contributed by Jack L. Strominger

Abstract

Quantitative and qualitative defects in CD1d-restricted T cells have been demonstrated in human and murine autoimmune diseases. To investigate the transcriptional consequences of T cell receptor activation in human Vα24JαQ T cell clones, DNA microarrays were used to quantitate changes in mRNA levels after anti-CD3 stimulation of clones derived from identical twins discordant for type 1 diabetes and IL-4 secretion. Activation resulted in significant modulation of 226 transcripts in the IL-4 secreting clone and 86 in the IL-4-null clone. Only 28 of these genes were in common. The differences observed suggest both ineffective differentiation of diabetic Vα24JαQ T cells and a role for invariant T cells in the recruitment and activation of cells from the myeloid lineage.

Footnotes

  • To whom reprint requests should be addressed. E-mail: mbyrne{at}genetics.com (M.C.B.) or brian_wilson{at}dfci.harvard.edu (S.B.W.).

  • See commentary on page 6933.

  • Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.120161297.

  • Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.120161297

  • Abbreviations:
    Th,
    T helper;
    PI3-kinase,
    phosphoinositide-3-OH kinase;
    PMA,
    phorbol 12-myristate 13-acetate
« Previous | Next Article »Table of Contents